27 March 2020 - Deborah Wilkes
Archived
Mylan and Pfizer have announced that the planned combination of Mylan with Pfizer’s Upjohn business is now expected to close in the second half of 2020 due to the COVID-19 pandemic.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.